HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Does US full vaccination against COVID-19 immunize correspondingly S&P500 index: Evidence from the NARDL approach.

Abstract
This study analyzes the impact of COVID-19 full vaccination shocks on the US stock market in the period January 14, 2021- August 20, 2021. Using the Nonlinear Autoregressive Distributed Lag model, we find that the positive and negative COVID-19 full vaccination growth shocks have a positive and symmetrical impact on the US stock market over the long run. Additionally, the short-run findings provide that the US stock market reacts negatively with delay to the positive and negative COVID-19 full vaccination growth shocks. The study findings provide good insights that COVID-19 full vaccination immunizes accordingly to the S&P 500 index in the long run. The study results indicate that the impact of positive and negative COVID-19 full vaccination growth shocks on the stock market in the short run differs from that in the long run. This research bears important implications: governments should implement preventive measures with vaccination to recover the stock market. Policy makers ought to urge adopting policy measures to reduce panic and boost investor confidence during economic and health crises.
AuthorsHanen Atri, Hanen Teka, Saoussen Kouki
JournalHeliyon (Heliyon) Vol. 9 Issue 4 Pg. e15332 (Apr 2023) ISSN: 2405-8440 [Print] England
PMID37057049 (Publication Type: Journal Article)
Copyright© 2023 Published by Elsevier Ltd.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: